Navigation Links
Double Blind Study Proves The Pink Patch Works for Weight Loss
Date:12/15/2008

Independent physician's study confirms the efficacy of The Pink Patch for weight control with an average weight loss of 6.1 lbs. (2.7 kg) in 4 weeks. The Pink Patch is a once-a-day topical patch designed to help individuals achieve their weight loss goals. Dr. Hudson stated in her findings, "The results demonstrated that in the absence of any dietary or activity changes, The Pink Patch, can potentially help increase weight loss and make positive changes in body dimensions through the delivery of active ingredients."

Sheffield, United Kingdom (PRWEB) December 12, 2008 -- Renowned physiologist Dr. Annette Hudson recently conducted a double-blind, observational independent study to determine the efficacy of The Pink Patch. Over a 4-week period, study participants who used The Pink Patch with active herbal ingredients experienced:

- Average weight loss of 2.9 lbs (1.3 kg) in the first week

- Average weight loss of 6.1 lbs. (2.7 kg) after 4 weeks

- Decrease of 2.8 inches (7.1 cm) on average including hips, waist, thighs, biceps and chest over 4 weeks

- BMI decrease of 1 unit over 4 weeks

The "placebo" group demonstrated virtually no weight loss, no change in BMI (body mass index, which determines body fat) or change in inches on hips, waist, thighs, biceps or chest.

This study shows that the weight loss benefits of using The Pink Patch are not due to a "placebo" effect, but rather the combination of active herbal ingredients present when The Pink Patch is used daily, as recommended.

Dr. Hudson stated in her findings, "The results demonstrated that in the absence of any dietary or activity changes, The Pink Patch, can potentially help increase weight loss and make positive changes in body dimensions through the delivery of active ingredients."

The participants in the study were separated in
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Stopping Statins After Stroke Doubles Death Risk
2. New Report: Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest
3. Guardians Dental Network Experiences Double-Digit Growth
4. Researchers say lack of sleep doubles risk of death... but so can too much sleep
5. Making the Case: special double issue of Critical Inquiry
6. Double cardiovascular benefit for people with chronic kidney disease
7. Anti-depressant drugs can double risk of gastrointestinal bleeding
8. Chronic job strain doubles the risk of a second heart attack
9. Congress Should Redouble Efforts to Increase Federal Cigarette Tax
10. More Women Choosing Preventive Double Mastectomy
11. NIH doubles support for vital HIV/AIDS research center
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Children's Hospital Surgeon Receives Prestigious Paul Tessier Medal 2Health News:Fertility Fact vs. Fiction: Women Recognizing Age as a Major Obstacle 2Health News:Fertility Fact vs. Fiction: Women Recognizing Age as a Major Obstacle 3Health News:VHI Releases Annual Industry Report - Highlights Hospital, Nursing Facility Efficiency 2Health News:Bears Quarterback Jay Cutler and Eli Lilly and Company Will Send 44 Kids to American Diabetes Association Camps Through the Touchdowns for Diabetes Campaign 2Health News:Bears Quarterback Jay Cutler and Eli Lilly and Company Will Send 44 Kids to American Diabetes Association Camps Through the Touchdowns for Diabetes Campaign 3Health News:Bears Quarterback Jay Cutler and Eli Lilly and Company Will Send 44 Kids to American Diabetes Association Camps Through the Touchdowns for Diabetes Campaign 4Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis 2Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis 3Health News:National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis 4
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 1Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 2Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 3BioCryst to Present at UBS Global Life Sciences Conference 57575 1BioCryst to Present at UBS Global Life Sciences Conference 57575 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 1Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 3Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 4Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 5Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 6Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 7Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 8Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 9Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 10Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 11Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 12Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 13Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 14Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 15